Biotie Therapies, which is developing a therapy to extend the efficacy of levodopa for Parkinson's disease, raised $56 million by offering 3.8 million ADSs at $14.888. Biotie Therapies plans to list on the NASDAQ under the symbol BITI. Biotie Therapies initially filed confidentially on 3/17/2015. RBC Capital Markets and Stifel acted as lead managers on the deal.
